^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Anti-EphA2 CAR-T therapy

    i
    Other names: Anti-EphA2 CAR-T therapy
    Associations
    News
    Trials
    Company:
    SenlangBio
    Drug class:
    EphA2-targeted CAR-T immunotherapy
    Associations
    News
    Trials